סימביקורט טורבוהלר 1604.5 מקגמנה ישראל - עברית - Ministry of Health

סימביקורט טורבוהלר 1604.5 מקגמנה

astrazeneca (israel) ltd - budesonide micronized; formoterol fumarate - אבקה לשאיפה - budesonide micronized 160 mcg/dose; formoterol fumarate 4.5 mcg/dose - formoterol and budesonide - formoterol and other drugs for obstructive airway diseases - asthma symbicort turbuhaler is indicated in the regular treatment of asthma in adults and adolescents age 12 years and above where use of a combination (inhaled corticosteroid and long acting beta-agonist) is appropriate: - patients not adequately controlled with inhaled corticosteroids and " as needed" inhaled short acting beta2- agonists. or - patients already adequately controlled on both inhaled corticosteroids and long acting beta2- agonists. copd symptomatic treatment of patients with severe copd (fev1 < 50 % predicted normal) and a history of repeated exacerbations who have significant symptoms despite regular therapy with long-acting bronchodilators.

אוטרוגסטן 200 ישראל - עברית - Ministry of Health

אוטרוגסטן 200

cts ltd - progesterone micronized - קפסולות - progesterone micronized 200 mg - progesterone

סימביקורט טורבוהלר 804.5 מקגמנה ישראל - עברית - Ministry of Health

סימביקורט טורבוהלר 804.5 מקגמנה

astrazeneca (israel) ltd - budesonide micronized; formoterol fumarate - אבקה לשאיפה - budesonide micronized 80 mcg/dose; formoterol fumarate 4.5 mcg/dose - formoterol and budesonide - formoterol and other drugs for obstructive airway diseases - symbicort turbuhaler is indicated in the regular treatment of asthma where use of a combination (inhaled corticosteroid and long acting beta-agonist) is appropriate: - patients not adequaterly controlled with inhaled corticosteroids and " as needed" inhaled short acting beta2- agonists. - or patients already adequately controlled on both inhaled corticosteroids and long acting beta2- agonists. note: symbicort turbuhaler 80/4.5 mcg/dose is not appropriate in patients with severe asthma.

סימביקורט טורבוהלר 3209  מקגמנה ישראל - עברית - Ministry of Health

סימביקורט טורבוהלר 3209 מקגמנה

astrazeneca (israel) ltd - budesonide micronized; formoterol fumarate - אבקה לשאיפה - budesonide micronized 320 mcg/dose; formoterol fumarate 9 mcg/dose - formoterol and budesonide - formoterol and other drugs for obstructive airway diseases - symbicort turbuhaler is indicated in the regular treatment of asthma in adults and adolescents (over the age of 12 years) where use of a combination (inhaled corticosteroid and long acting beta-agonist) is appropriate: - patients not adequaterly controlled with inhaled corticosteroids and " as needed" inhaled short acting beta2- agonists. - or patients already adequately controlled on both inhaled corticosteroids and long acting beta2- agonists. copd symptomatic treatment of patients with severe copd (fev1 < 50 % predicted normal) and a history of repeated exacerbations who have significant symptoms despite regular therapy with long-acting bronchodilators.

דמעות וזיעה ישראל - עברית - Ministry of Health

דמעות וזיעה

לאון מזרחי - זיוה מזרחי - איפור

לטקס ישראל - עברית - Ministry of Health

לטקס

לאון מזרחי - זיוה מזרחי - איפור

מקבע איפור ישראל - עברית - Ministry of Health

מקבע איפור

לאון מזרחי - זיוה מזרחי - מקבע איפור

NERVE STIMULATORS + NeuroNavigation System ישראל - עברית - Ministry of Health

nerve stimulators + neuronavigation system

בפקס בע"מ - מומחה - לשימוש בבתי חולים ואוניברסיטאות

נזוקורט אקווה 32 מקגמנה ישראל - עברית - Ministry of Health

נזוקורט אקווה 32 מקגמנה

astra zeneca (israel) ltd - budesonide micronized - ספריי לאף - budesonide micronized 0.64 mg/ml - budesonide - budesonide - seasonal and perennial allergic rhinitis, and vasomotor rhinitis. preventively against nasal polyps after polypectomy. symptomatic treatment in nasal polyposis.